Zobrazeno 1 - 10
of 33
pro vyhledávání: '"B O, Roep"'
Autor:
C, Pfleger, A, Kaas, L, Hansen, B, Alizadeh, P, Hougaard, R, Holl, H, Kolb, B O, Roep, H B, Mortensen, N C, Schloot, Jan Aman, Aman
Publikováno v:
Pfleger, C, Kaas, A, Hansen, L, Alizadeh, B, Hougaard, P, Holl, R, Kolb, H, Roep, B O, Mortensen, H B, Schloot, N C & Hvidøre Study Group on Childhood Diabetes 2008, ' Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes ', Clinical Immunology, vol. 128, no. 1, pp. 57-65 . https://doi.org/10.1016/j.clim.2008.03.458
Clinical Immunology, 128(1), 57-65. ACADEMIC PRESS INC ELSEVIER SCIENCE
Clinical Immunology. ACADEMIC PRESS INC ELSEVIER SCIENCE
Clinical Immunology, 128(1), 57-65. San Diego, CA: Academic Press (2008).
Clinical Immunology, 128(1), 57-65. ACADEMIC PRESS INC ELSEVIER SCIENCE
Clinical Immunology. ACADEMIC PRESS INC ELSEVIER SCIENCE
Clinical Immunology, 128(1), 57-65. San Diego, CA: Academic Press (2008).
Th1 related chemokines CCL3 and CCL5 and Th2 related CCL4 as ligands of the receptor CCR5 contribute to disease development in animal models of type 1 diabetes. In humans, no data are available addressing the role of these chemokines regarding diseas
Autor:
Johannes A Maassen, B. O. Roep, Leen M 't Hart, E. H. R. Van Essen, J. J. Jansen, Herman H.P.J. Lemkes, J. M. W. van den Ouweland
Publikováno v:
Diabetic Medicine. 17:841-847
SUMMARY Aim Maternally inherited diabetes and deafness (MIDD) associates with a mutation at position 3243 in mitochondrial DNA. Phenotypic expression of MIDD includes Type 1-like and Type 2-like diabetes. This study examined whether HLA-DQ phenotype
Autor:
B. O. Roep
Publikováno v:
Diabetes. 45:1147-1156
Autor:
B. O. Roep, A. A. Kallan, G. Duinkerken, S. D. Arden, J. C. Hutton, G. J. Bruining, R. R. de Vries
Publikováno v:
Diabetes. 44:278-283
Autor:
S Martin, P Rieckmann, I Melchers, R Wagner, J Bertrams, A E Voskuyl, B O Roep, J Zielasek, E Heidenthal, I Weichselbraun
Publikováno v:
The Journal of Immunology. 154:1951-1955
The intercellular adhesion molecule-3 (ICAM-3) has been identified as the third LFA-1 ligand in addition to ICAM-1 and ICAM-2. In this report we have identified circulating forms of ICAM-3 (cICAM-3) in human serum. Using a sandwich ELISA with two mon
Autor:
W. L. W. Hazenbos, A. A. Kallan, E M Bailyes, Joke Bruining, Susan D. Arden, Ezio Bonifacio, B. O. Roep, John C. Hutton, R. R. P. De Vries, Christian Boitard
Publikováno v:
Journal of Endocrinological Investigation. 17:559-563
Autor:
A, Kaas, C, Pfleger, A V, Kharagjitsingh, N C, Schloot, L, Hansen, K, Buschard, B P C, Koeleman, B O, Roep, H B, Mortensen, B Z, Alizadeh, Jan, Åman
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 29(6)
The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFNγ) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1 diabetes.Two hundred and twenty-seven patients from th
Autor:
A, Kaas, C, Pfleger, L, Hansen, K, Buschard, N C, Schloot, B O, Roep, H B, Mortensen, Jan, Aman
Publikováno v:
Clinical and Experimental Immunology, 161(3), 444-452
P>The progression of type 1 diabetes after diagnosis is poorly understood. Our aim was to assess the relation of disease progression of juvenile-onset type 1 diabetes, determined by preserved beta cell function the first year after diagnosis, with sy
Publikováno v:
Diabetes. 41:1380-1384
Autor:
Stephan Martin, S. Kappler, Pejman Hanifi-Moghaddam, Hubert Kolb, B. O. Roep, Sylvia Müller-Scholze, Klaus Strassburger, Nanette C. Schloot, J. Seissler
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 23(2)
Aims The hypothesis was tested in an exploratory study that individuals at high risk of developing Type 1 diabetes mellitus have altered systemic levels of cytokines and chemokines. Subjects and methods Forty-two non-diabetic first-degree relatives o